Antisense Therapeutics: Raises $7.3M for DMD treatment
Antisense Therapeutics (ANP) has raised $7.3 million for its Duchenne muscular dystrophy (DMD) treatment
The company will issue 73 million shares at 10...
Brookside Energy: Announces Jewell Well development fund
Oil and gas company Brookside Energy (BRK) has launched a new funding initiative for its Jewell Well development in Oklahoma
As part of...
Straker Translations: Signs extended IBM appointment
Straker Translations (STG) appointed as the Strategic Translation Service Provider to leading computer hardware manufacturer IBM
The new agreement will last for two...
Buddy Technologies: Raises $13M for growth
Smart tech company Buddy Technologies (BUD) has received firm commitments to undertake a $13 million placement
All up, 271 million fully paid ordinary...
Remote: Secures $35M in Series A Funding
Remote, a San Francisco, CA-based provider of an HR technology platform for international payroll, benefits, and compliance, raised $35m in Series A funding.
...
Carbon Health: Secures $100M in Series C Funding
Carbon Health, a San Francisco, CA-based technology-enabled healthcare provider, secured $100m in Series C funding
The round was led by Dragoneer Investment Group,...
Hopin: Raises $125M for its online events platform on the back of surging growth
This morning Hopin, a startup that provides online events software, announced that it has closed a $125 million Series B round of capital
...
Little Green Pharma: Partners with HIF
Medicinal cannabis company Little Green Pharma (LGP) has entered a strategic partnership with private health insurer HIF
Under the deal, HIF will issue...
Immutep: Reveals encouraging interim results from phase two TACTI-002 study
Immutep (IMM) has released further interim data from its Phase II TACTI-002 Study in patients with lung, head, and neck cancers
The study...
